Johnson & Johnson (JNJ) Earnings History
Growth Compounder37 years of earnings data (1989–2025) · Consistent double-digit EPS growth over 5 years
Loading earnings history...
Johnson & Johnson (JNJ) Earnings Overview
As of September 23, 2026, Johnson & Johnson (JNJ) reported trailing twelve-month net income of $21.42B, reflecting +90.5% year-over-year growth. The company earned $8.78 per diluted share over the past four quarters, with a net profit margin of 28.5%.
Looking at the long-term picture, JNJ's 5-year EPS compound annual growth rate (CAGR) stands at +14.9%, showing solid earnings momentum. The company achieved its highest annual net income of $35.15B in fiscal 2023.
Johnson & Johnson maintains industry-leading profitability with a gross margin of 72.8%, operating margin of 27.2%, and net margin of 28.5%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including ABT ($6.28B net income, 14.7% margin), PFE ($4.33B net income, 12.4% margin), MRK ($3.17B net income, 28.1% margin), JNJ has outperformed on profitability metrics. Compare JNJ vs ABT →
JNJ Earnings vs Peers
Earnings metrics vs comparable public companies
JNJ Historical Earnings Data (1989–2025)
37 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $26.80B | +90.6% | $25.60B | $11.03 | 28.5% | 27.2% |
| 2024 | $14.07B | -60.0% | $22.15B | $5.79 | 15.8% | 24.9% |
| 2023 | $35.15B | +95.9% | $23.41B | $13.72 | 41.3% | 27.5% |
| 2022 | $17.94B | -14.1% | $21.01B | $6.73 | 22.4% | 26.3% |
| 2021 | $20.88B | +41.9% | $20.94B | $7.81 | 26.5% | 26.6% |
| 2020 | $14.71B | -2.7% | $19.73B | $5.51 | 17.8% | 23.9% |
| 2019 | $15.12B | -1.2% | $20.97B | $5.63 | 18.4% | 25.6% |
| 2018 | $15.30B | +1076.7% | $21.18B | $5.61 | 18.8% | 26.0% |
| 2017 | $1.30B | -92.1% | $18.90B | $0.47 | 1.7% | 24.7% |
| 2016 | $16.54B | +7.3% | $20.89B | $5.93 | 23.0% | 29.1% |
| 2015 | $15.41B | -5.6% | $18.29B | $5.48 | 22.0% | 26.1% |
| 2014 | $16.32B | +18.0% | $21.14B | $5.70 | 22.0% | 28.4% |
| 2013 | $13.83B | +27.4% | $18.96B | $4.81 | 19.4% | 26.6% |
| 2012 | $10.85B | +12.2% | $17.03B | $3.86 | 16.1% | 25.3% |
| 2011 | $9.67B | -27.5% | $16.15B | $3.49 | 14.9% | 24.8% |
| 2010 | $13.33B | +8.7% | $16.53B | $4.78 | 21.7% | 26.8% |
| 2009 | $12.27B | -5.3% | $16.66B | $4.40 | 19.8% | 26.9% |
| 2008 | $12.95B | +22.4% | $16.17B | $4.57 | 20.3% | 25.4% |
| 2007 | $10.58B | -4.3% | $15.21B | $3.63 | 17.3% | 24.9% |
| 2006 | $11.05B | +9.9% | $13.71B | $3.73 | 20.7% | 25.7% |
| 2005 | $10.06B | +23.0% | $12.83B | $3.35 | 19.9% | 25.4% |
| 2004 | $8.18B | +13.7% | $12.36B | $2.74 | 17.3% | 26.1% |
| 2003 | $7.20B | +9.1% | $10.87B | $2.29 | 17.2% | 26.0% |
| 2002 | $6.60B | +16.4% | $9.68B | $2.16 | 18.2% | 26.7% |
| 2001 | $5.67B | +14.4% | $7.88B | $1.84 | 17.5% | 24.4% |
| 2000 | $4.95B | +15.9% | $6.62B | $1.61 | 17.0% | 22.7% |
| 1999 | $4.27B | +42.3% | $5.99B | $1.39 | 15.3% | 21.4% |
| 1998 | $3.00B | -9.1% | $5.03B | $1.06 | 12.5% | 21.0% |
| 1997 | $3.30B | +14.4% | $4.62B | $1.21 | 14.6% | 20.4% |
| 1996 | $2.89B | +20.1% | $4.30B | $1.09 | 13.4% | 19.9% |
| 1995 | $2.40B | +19.8% | $3.51B | $0.93 | 12.8% | 18.6% |
| 1994 | $2.01B | +12.3% | $2.81B | $0.78 | 12.7% | 17.8% |
| 1993 | $1.79B | +73.5% | $2.39B | $0.68 | 12.6% | 16.9% |
| 1992 | $1.03B | -29.5% | $2.28B | $0.16 | 7.5% | 16.6% |
| 1991 | $1.46B | +27.8% | $2.16B | $0.54 | 11.7% | 17.4% |
| 1990 | $1.14B | +5.6% | $1.99B | $0.43 | 10.2% | 17.7% |
| 1989 | $1.08B | - | $1.66B | $0.40 | 11.1% | 17.0% |
Download Data
Export JNJ earnings history in CSV or JSON format
Free sign-in required to download data
JNJ Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
JNJ Stock Analysis
Bull/bear thesis, analyst target revisions, and earnings execution.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
37+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
JNJ — Frequently Asked Questions
Quick answers to the most common questions about buying JNJ stock.
What is JNJ earnings per share (EPS)?
JNJ trailing twelve-month (TTM) diluted EPS is $8.78, reflecting +90.5% year-over-year growth. The 5-year EPS CAGR is +14.9%. Complete EPS history from 1989 to 2025 is available in the table on this page.
What is Johnson & Johnson's net income?
Johnson & Johnson (JNJ) trailing twelve-month net income is $21.4B as of 2025. Earnings grew +90.5% year-over-year. Johnson & Johnson has been profitable for 37 consecutive years.
Is JNJ profitable?
Yes, JNJ is profitable with a TTM net income of $21.4B and a net profit margin of +28.5%. Johnson & Johnson has generated profits for 37 consecutive years.
What is JNJ's earnings growth rate?
JNJ compound annual EPS growth rates (CAGR): 1-Year: +90.5%, 3-Year: +17.9%, 5-Year: +14.9%, 10-Year: +7.2%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1989 to 2025.
What are JNJ's profit margins?
Johnson & Johnson net profit margin is +28.5%, operating margin is +27.2%, and gross margin is +72.8%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +35.0%.
Is JNJ growing earnings?
Yes, JNJ earnings are accelerating — EPS growth of +90.5% exceeds the 5-year CAGR of +14.9%. TTM net income reached $21.4B. Earnings momentum is strengthening.
What was JNJ's best earnings year?
Johnson & Johnson's highest annual net income on record is $35.2B, achieved in fiscal year 2023. Earnings history on this page spans 1989 to 2025 and includes all annual and quarterly figures.
What were JNJ's earnings last quarter?
JNJ's most recent reported quarter was Q2 2026. Net income was $5.5B with diluted EPS of $2.27. For a full breakdown of all quarters, see the quarterly earnings table on this page.